This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

Christoph U. Correll, MD

Published: October 14, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

In many clinical settings, secondgenerationantipsychotics are preferred overfirst-generation antipsychotics because theycause fewer acute1 and chronic2 neuromotorside effects. In addition, second-generationantipsychotics may have improved3,4 andbroader5 efficacy and are potentially associatedwith somewhat lower rates of nonadherence6compared with those of the olderagents. However, since the late 1990s, the increasedrisk for weight gain associated withsecond-generation antipsychotics has becomea focus of attention.’ ‹’ ‹

Volume: 66

Quick Links: Metabolic Disorder , Side Effects-Medication

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...